Median-based incremental cost-effectiveness ratio (ICER)

Journal of Statistical Theory and Practice

Volumn 6, Issue 3, 2012, Pages 428-442

  Bang, Heejung ^a   Zhao, Hongwei ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cost effectiveness analysis; Cost effectiveness plane; Mean cost; Median cost

Indexed keywords

EID: 84865232600     PISSN: 15598608     EISSN: 15598616     Source Type: Journal    
DOI: 10.1080/15598608.2012.695571     Document Type: Article

References (44)

1. Bang, H., and A. A. Tsiatis. 2002. Median regression with censored cost data. Biometrics, 58, 643-649. (Pubitemid 35001482)
2. Black, W. C. 1990. The CE plane: A graphic representation of cost-effectiveness. Med. Decision Making 10, 212-214. (Pubitemid 20311440)
3. Bloomfield, D. J., M. D. Krahn, T. Neogi, et al. 1998. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: Based on a Canadian randomized trial with palliative end points. J. Clin. Oncol., 16, 2272-2279. (Pubitemid 28265068)
4. Blumenschein, K., M. Johannesson, K. K. Yokoyama, and P. R. Freeman. 2001. Hypothetical versus real willingness to pay in the health care sector: Results from a field experiment. J. Health Econ., 20, 441-457. (Pubitemid 32331842)
5. Briggs, A. 2000. Economic evaluation and clinical trials: Size matters: The need for greater power in cost analyses poses an ethical dilemma. Br. Med. J., 321, 1362-1363.
6. Brookmeyer, R. 2005. Median survival time. In Encyclopedia of biostatistics, ed. P. Armitage and T. Colton. New York, John Wiley & Sons.
7. Chaudhary, M. A., and S. C. Stearns. 1996. Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial. Stat. Med., 15, 1447-1458. (Pubitemid 26242553)
8. Dinh, P., and X.-H. Zhou. 2006. Nonparametric statistical methods for cost-effectiveness analyses. Biometrics, 62, 576-588. (Pubitemid 43926664)
9. Drummond, M. F., M. J. Sculpher, G. W. Torrance, B. J. O'Brien, and G. L. Stoddart. 2005. Methods for the economic evaluation of health care programmes, 3rd ed. Oxford, Oxford University Press.
10. Duan, N. 1983. Smearing estimate: A nonparametric retransformation method. JASA 78, 605-610.
11. Fan, M. Y., and Zhou, X. H. 2007. A simulation study to compare methods for constructing confidence intervals for the incremental cost-effectiveness ratio. Health Serv. Outcomes Res. Method, 7, 57-77.
12. Fenwick, E., K. Claxton, and M. J. Sculpher. 2001. Representing uncertainty: The role of costeffectiveness acceptability curves. Health Econ. 10, 779-787. (Pubitemid 34041389)
13. Garber, A. M., and C. E. Phelps. 1997. Economic foundations of cost-effectiveness analysis. J. Health Econ., 16, 1-31. (Pubitemid 27224092)
14. Gardiner, J. C., C. J. Bradley, and M. Huebner. 2000. The cost-effectiveness ratio in the analysis of health care programs. In Handbook of Statistics, Bioenvironmental and Public Health Statistics 18, eds. Rao, C. R., and P. K. Sen. pp. 841-869, North Holland.
15. Gardiner, J. C., M. Huebner, H. Jetton, and C. J. Bradley. 2001. On parametric confidence intervals for the cost-effectiveness ratio. Biometrical J., 43, 283-296.
16. Gardiner, J. C., C. M. Sirbu, and M. H. Rahbar. 2004. Update on statistical power and sample size assessments for cost-effectiveness studies. Expert Rev. Pharmacoecon. Outcomes Res., 4, 89-98. (Pubitemid 38213097)
17. Gold, M. R., J. E. Sigel, L. B. Russell, and M. C. Weinstein (eds.). 1996. Cost-effectiveness in health and medicine. New York, Oxford University Press.
18. Heitjan, D. F., A. J. Moskowitz, and W. Whang. 1999a. Bayesian estimation of cost-effectiveness ratios from clinical trials. Health Econ., 8, 191-201. (Pubitemid 29219084)
19. Heitjan, D. F., A. J. Moskowitz, and W. Whang. 1999b. Problems with interval estimates of the incremental cost-effectiveness ratio. Med. Decision Making, 19, 9-15. (Pubitemid 29031789)
20. Heshmat, S. 2003. Cost-effectiveness analysis. In Encyclopedia of biopharmaceutical statistics, ed. S.-C. Chow. p. 363-368, Informa Health Care.
21. Hwang, J. T. G. (1995). Fieller's problems and resampling techniques. Stati. Sin., 5, 167-171.
22. Jiang, G., J.Wu, and G. R.Williams. 2000. Fieller's interval and the bootstrap-Fieller interval for the incremental cost-effectiveness ratio. Health Serv. Outcomes Res. Method, 1, 291-303.
23. Laska, E. M., M. Meisner, C. Siegel, and A. A. Stinnett. 1999. Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence. Health Econ., 8, 171-174. (Pubitemid 29178569)
24. Neumann, P. J. 2004. Why don't Americans use cost-effectiveness analysis? Am. J. Managed Care, 10, 308-312. (Pubitemid 38623521)
25. O'Brien, B. J., and A. H. Briggs. 2002. Analysis of uncertainty in health care cost-effectiveness studies: An introduction to statistical issues and methods. Stat. Methods Med. Res., 11, 455-468. (Pubitemid 36096865)
26. Obenchain, R. L. 1999. Resampling and multiplicity in cost-effectiveness inference. J. Biopharm. Stat. 9, 563-582. (Pubitemid 29535948)
27. Obenchain, R. L. 2008. ICE preference maps; Nonlinear generalizations of net benefit and acceptability. Health Serv Outcomes Res. Method, 8, 31-56.
28. Obenchain, R. L., and B. M. Johnstone. 1999. Mixed-model imputation of cost data for early discontinuers from a randomized clinical trial. Drug Information J., 33, 191-209. (Pubitemid 29104666)
29. Obenchain, R. L., and J. A. Sacristan. 1997. In reply to "The negative side of cost-effectiveness ratios." J. Am, Med. Assoc., 277, 1931-1933. (Pubitemid 27272765)
30. Ramsey, S., R.,Willke, A. Briggs, et al. 2005. Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force report. Value Health, 8, 521-533. (Pubitemid 41727304)
31. Rossner, M., H. Van Epps, and E. Hill. 2007. Show me the data. J. Cell Biol., 179, 1091-1092. (Pubitemid 350277727)
32. Siegel, J. E., M. C. Weinstein, L. B. Russell, and M. R. Gold. 1996. For the Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses. J. Am. Med. Assoc., 276, 1339-1341.
33. Stinnett, A. A. 1996. Adjusting for bias in C/E ratio estimates. Health Econ., 5, 470-472.
34. Stinnett, A. A., and J. Mullahy. 1997. The negative side of cost-effectiveness analysis. J. Am. Med. Assoc., 277, 1931-1932.
35. Stinnett, A. A., and J. Mullahy. 1998. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Med. Decision Making, 18, S68-S80. (Pubitemid 28175944)
36. Tannock, I. F., D. Osoba, M. R. Stockler. et al. 1996. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points. J. Clin. Oncol., 14, 1756-1764. (Pubitemid 26185452)
37. Tollefson, G. D., C.M. Beasley, P. V. Tran, et al. 1997. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial. Am. J. Psychiatry, 154, 457-465. (Pubitemid 27147597)
38. Van Hout, B., M. Al, G. Gordon, and F. Rutten. 1994. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ., 3, 309-319.
39. Wang, H., and H. Zhao. 2008. A study on confidence intervals for incremental cost-effectiveness ratios. Biometrical J., 50, 505-514.
40. Weinstein, M. C., and W. B. Stason. 1977. Foundations of cost-effectiveness analysis for health and medical practice. N. Engl. J. Med., 296, 716-721. (Pubitemid 8066534)
41. Zhao, H., H. Bang, H. Wang, and P. E. Pfeifer. 2007. On the equivalence of some medical cost estimators with censored data. Stat. Med., 26, 4520-4530. (Pubitemid 47534695)
42. Zhao, H., and L. Tian. 2001. On estimating medical cost and incremental cost-effectiveness ratios with censored data. Biometrics, 57, 1002-1008. (Pubitemid 33108090)
43. Zhao, H., C. Zuo, S. Chen, and H. Bang. (In press). Nonparametric inference for median costs with censored data. Biometrics.
44. Zhou, X. H., C. A. Melfi, and S. L. Hui. 1997. Methods for comparison of cost data. Ann. Intern. Med., 127, 752-756. (Pubitemid 27446561)